LAI Antipyschotics

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Wed, 03/27/2024 - 17:35
#1
Brian Mun
Brian Mun's picture
Offline
Last seen: 7 months 3 weeks ago
Joined: 03/17/2024 - 21:03
LAI Antipyschotics

We're working on re-establishing our formulary for long-acting-injectable antipsychotics and currently developing a class review. In order to cover the most amount of patients while taking into account cost (we have 340b pricing) we're thinking of choosing Fluphenazine, Abilify maintena, and Risperdal consta. After speaking with our medical pysch team, we are also thinking of considering Invega Sustenna, Uzedy, and potentially Rexulti.

Just wanted to hear the thoughts everyone else had on their class review for choosing formularies.

Top